Merit Cudkowicz

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cytonkinetics
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pasithea
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ono
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Roche
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Denali
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Immunity Pharm
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    RRD
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    MTPC
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Inflectis
    Topic:
    Consultant
    Date added:
    11/13/2023
    Date updated:
    01/23/2024

Pages

Return to 129 NEUROLOGY GRAND ROUNDS "What Is New In ALS Diagnostics, Care and Therapeutics" (022124)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.